Resistance to Chemotherapy and Molecularly Targeted Therapies: Rationale for Combination Therapy in Malignant Melanoma

E-ISSN： 1875-5666|11|7|553-563

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.11, Iss.7, 2011-10, pp. : 553-563

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guest editorial: efficacy of and resistance to molecularly targeted therapy for myeloid malignancies

By Kiyoi Hitoshi

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 681-682

Springer Publishing Company

Access to resources Recommend Favorite

Asthma Pathophysiology and the Scientific Rationale for Combination Therapy

By Schieken Lawrence S.

Allergy and Asthma Proceedings, Vol. 23, Iss. 4, 2002-07 ,pp. : 247-251

OceanSide Publications, Inc

Access to resources Recommend Favorite

The Impact of Molecularly Targeted Therapies Upon the Understanding of Leukemogenesis and the Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia

Current Stem Cell Research & Therapy, Vol. 5, Iss. 4, 2010-12 ,pp. : 372-378

Bentham Science Publishers

Access to resources Recommend Favorite

Methotrexate and gemcitabine combination chemotherapy for the treatment of malignant pleural mesothelioma

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 639-642

Spandidos Publications

Access to resources Recommend Favorite

Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 805-810

Spandidos Publications

Access to resources Recommend Favorite